According to the American Cancer Society, prostate cancer is the most common type of cancer found in American men, other than skin cancer.
Immunotherapy is the new black when it comes to treating Cancer, raising hope in conquering this age old illness.
BREAKING NEWS: Advaxis Reports Preliminary Safety and Survival Data from a Phase 2 Trial in Recurrent/Refractory Cervical Cancer
Advaxis is a clinical-stage biotechnology company developing the next generation of immunotherapies.
The idea of using harmful bacteria to treat disease might strike many as an odd concept.